Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

84448445844684478448844984508451845284538454845584568457845884598460846184628463846484658466846784688469847084718472847384748475847684778478847984808481848284838484848584868487848884898490849184928493Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modalityimpact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-1034.Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques andspiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86-91.Seymour MT, Maughan TS, Ledermann JA, topham C, James R, Swyther SJ et al. FOCUS Trial Investigators:National Cancer Research Institute Colorectal Clinical Studies Group. Different strategies of sequential andcombination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): arandomised trial. Lancet 2007:370:143-52.Seymour MT, Thompson LC, Wasan HS, et al. Chemotherapy options in elderly and frail patients with metastaticcolorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet 2011;377:1749-59.Shaha, M., Cox, C.L., Talman, K. & Kelly, D. (2008). Uncertainty in breast, prostate, and colorectal cancer:implications for supportive care. Journal of Nursing scholarship,( 40), 60-67.Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, et al. Patterns of morphologic alteration in residualrectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J SurgPathol 2004;28:215-23.Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases fromcolorectal carcinoma. Cancer. 2000 Jul 15;89(2):276-84Shimamura T, Nakajima Y, Une Y, et al. Efficacy and safety of preoperative percutaneous transhepatic portalembolization with absolute ethanol: a clinical study. Surgery 1997;121:135-141.Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis.Colorectal Cancer Collaborative Group. BMJ 2000;321(7260):531-5.Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005Oct;25 Suppl 1:S69-83.Simon D. Das Rektumkarzinom--die onkologisch adaquate Resektion. [Rectal carcinoma--oncologicallyadequate resection]. Schweiz Rundsch Med Prax 2001;90:575-80.Simons PC, Van Steenbergen LN, De Witte MT, Janssen-Heijnen ML. Miss rate of colorectal cancer at CTcolonography in average-risk symptomatic patients. Eur Radiol. 2012 Oct 20. [Epub ahead of print]. PMID:23085864.Sinicrope FA, Shi Q. Combining molecular markers with the TNM staging system to improve prognostication instage II and III colon cancer: are we ready yet? J Natl Cancer Inst. 2012 Nov 7;104(21):1616-8. doi:10.1093/jnci/djs441. Epub 2012 Oct 25. PubMed PMID: 23104213.Sinicrope FA, Foster NR, Yoon HH, Smyrk TC, Kim GP, Allegra CJ, et al. Association of obesity with DNAmismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating inNCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol. 2012 Feb 1;30(4):406-12. doi:10.1200/JCO.2011.39.2563. Epub 2011 Dec 27. PubMed PMID: 22203756; PubMed Central PMCID:PMC3269966.Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, et al. DNA mismatch repair statusand colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl CancerInst. 2011 Jun 8;103(11):863-75. doi: 10.1093/jnci/djr153. Epub 2011 May 19. Erratum in: J Natl Cancer Inst.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 193